Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 17.08.2011 (4799
dage). |
Ingen historik.
Branche | Ikke-finansielle holdingselskaber (642020). |
Sidst opdateret den 10.05.2021 og
angivet som gældende fra 16.04.2021 (1269
dage). |
Historik | Start | Stop |
---|
Ikke-finansielle holdingselskaber (642020) | 16.04.2021 | |
Virksomhedsrådgivning og anden rådgivning om driftsledelse (702200) | 01.01.2021 | 15.04.2021 |
Ikke-finansielle holdingselskaber (642020) | 17.08.2011 | 31.12.2020 |
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 17.08.2011 (4799
dage). |
Ingen historik.
Kontaktoplysninger | info@cs-medica.com. |
Sidst opdateret den 13.06.2023 og
angivet som gældende fra 13.06.2023 (481
dage). |
Historik | Start | Stop |
---|
info@cs-medica.com | 13.06.2023 | |
glh@galaxapharma.com | 30.04.2021 | 12.06.2023 |
sillerenelone@gmail.com | 17.08.2011 | 29.04.2021 |
Telefonnummer | 27742280. |
Sidst opdateret den 30.04.2021 og
angivet som gældende fra 30.04.2021 (1255
dage). |
Historik | Start | Stop |
---|
27742280 | 30.04.2021 | |
43696014 | 17.08.2011 | 29.04.2021 |
Navne | CS MEDICA a/s. |
Sidst opdateret den 07.01.2022 og
angivet som gældende fra 09.12.2021 (1032
dage). |
Historik | Start | Stop |
---|
CS MEDICA a/s | 09.12.2021 | |
CS medica a/s | 16.04.2021 | 08.12.2021 |
CS Group ApS | 24.07.2020 | 15.04.2021 |
LHX HOLDING ApS | 17.08.2011 | 23.07.2020 |
Tegningsregel | Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem, af tre medlemmer af bestyrelsen eller af den samlede bestyrelse. |
Sidst opdateret den 07.01.2022 og
angivet som gældende fra 07.01.2022 (1003
dage). |
Fortolkning
(3 tegningsmuligheder)
| direktøren + 1 bestyrelsesmedlem |
3 bestyrelsesmedlemmer |
bestyrelsen |
Historik | Start | Stop |
---|
Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem, af tre medlemmer af bestyrelsen eller af den samlede bestyrelse | 07.01.2022 | |
Selskabet tegnes af den administrerende direktør i forening med formanden, af fire medlemmer af bestyrelsen eller af formanden i forening med to bestyrelsesmedlemmer | 30.04.2021 | 06.01.2022 |
Selskabet tegnes af ejeren | 17.08.2011 | 29.04.2021 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:Christensen Kjærulff
Revisionsvirksomhedens CVR-nr.:15915641
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class D
Grundlag for konklusion (revision):Basis for Opinion We conducted our audit in accordance with Interna-tional Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements and the Parent Company Financial Statements” section of our report. We are independent of the Group in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these require-ments and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Significant uncertainty regarding continued operationsIt is imperative to highlight the content of note 0 and in accounting policies under section “Critical accounting judgements and key sources of estimation uncertainty”, which describes the significant uncertainty associated with revenue and the entered investment agreement. Our conclusion remains unmodified regarding this matter.
Konklusion (revision):OpinionIn our opinion, the consolidated financial statements and the parent company financial statements give a true and fair view of the financial position of the Group and the Parent Company at 30 September 2023, and of the results of the Group and the Company’s operations as well as the consolidated cash flows for the financial year 1 October 2022 - 30 September 2023 in accordance with the International Financial Reporting Standards (IFRS) as issued by the International Accounting Stand-ards Board and in accordance with IFRS as endorsed by the EU and further requirements in the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review Management is responsible for Management’s Review. Our opinion on the consolidated financial statements and the parent company financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the consolidated financial statements and the parent company financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the consolidated financial statements and the parent company financial state-ments, or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act. Based on the work we have performed; we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accord-ance with the requirements of the Danish Financial State-ment Act. We did not identify any material misstatement of Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.